Within this context, MEDVi operates as a telehealth serviceaimed at providing physician-supervised GLP-1 weight-loss treatment
Tirzepatide is among a new class of drugs called GLP-1 receptor agonists, which are produced to treat type 2 diabetes
External resources New England Journal of Medicine: Tirzepatide Once Weekly for Treatment of Obesity PubMed Central: Efficacy of Tirzepatide vs Semaglutide in Type 2 Diabetes Endocrine Practice: Switching to Tirzepatide From GLP-1 Receptor Agonists In case I do not see you, good afternoon, good evening, and good night
GLP-1s for Polyendocrine Metabolic Ovarian Syndrome Women with polyendocrine metabolic ovarian syndrome (PMOS) produce excess testosterone, which can lead to painful, heavy, or irregular periods, infertility, excess facial and body hair, severe acne, and small cysts on the ovaries
If youre in the compounding business, its more important than ever to stay informed about FDA regulations and to ensure that your practices are fully compliant with the law